Search

Your search keyword '"Shanmugasundaram, Veerabahu"' showing total 187 results

Search Constraints

Start Over You searched for: Author "Shanmugasundaram, Veerabahu" Remove constraint Author: "Shanmugasundaram, Veerabahu"
187 results on '"Shanmugasundaram, Veerabahu"'

Search Results

2. Epilogue to the Gerald Maggiora Festschrift: a tribute to an exemplary mentor, colleague, collaborator, and innovator

4. The PROTACtable genome

6. Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2)

9. Delineating the role of cooperativity in the design of potent PROTACs for BTK

12. Driving Drug Discovery with Biophysical Information

14. Going Beyond R-Group Tables

16. Small molecule allosteric inhibitors of RORγt block Th17-dependent inflammation and associated gene expression in vivo

19. Structural basis for effectiveness of siderophoreconlugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa

23. Absence of GP130 cytokine receptor signaling causes extended Stüve-Wiedemann syndrome

24. Machine Learning for Prioritization of Thermostabilizing Mutations for G-Protein Coupled Receptors

32. TRPA1 ankyrin repeat six interacts with a small molecule inhibitor chemotype.

35. Discovery of a Selective Covalent Inhibitor of Lysophospholipase-like 1 (LYPLAL1) as a Tool to Evaluate the Role of this Serine Hydrolase in Metabolism

36. Discovery of a Highly Selective Glycogen Synthase Kinase‐3 Inhibitor (PF‐04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET Neuroimaging

37. Preface

39. Heterocyclic methylsulfone hydroxamic acid LpxC inhibitors as Gram-negative antibacterial agents

40. Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections

41. Corrigendum to “Novel monobactams utilizing a siderophore uptake mechanism for the treatment of Gram-negative infections” [Bioorg. Med. Chem. Lett. 22/18 (2012) 5989–5994]

42. Chemical and Computational Methods for the Characterization of Covalent Reactive Groups for the Prospective Design of Irreversible Inhibitors

45. Smoothened antagonists for hair inhibition

46. Multiparameter Optimization in CNS Drug Discovery: Design of Pyrimido[4,5-d]azepines as Potent 5-Hydroxytryptamine 2C (5-HT2C) Receptor Agonists with Exquisite Functional Selectivity over 5-HT2A and 5-HT2B Receptors

47. Siderophore Receptor-Mediated Uptake of Lactivicin Analogues in Gram-Negative Bacteria

49. Pyridone-Conjugated Monobactam Antibiotics with Gram-Negative Activity

50. Monitoring the Progression of Structure-Activity Relationship Information during Lead Optimization.

Catalog

Books, media, physical & digital resources